OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer ...
The Mikaela Naylon Give Kids a Chance Act, legislation expanding access to treatment of rare diseases in children, was signed ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Facebook on MSN
At 10 years old, she was diagnosed with osteosarcoma, a type of bone cancer, and had her affected bone replaced with an...
At 10 years old, she was diagnosed with osteosarcoma, a type of bone cancer, and had her affected bone replaced with an ...
Request for FDA Rolling Review submitted to FDA on January 30, 2026Non-Clinical and CMC BLA modules submitted to FDAAt FDA's ...
While genetic sequencing has previously helped to uncover different subtypes of other cancers, like breast or skin cancer, for which those patients then receive targeted treatment personalised to ...
HOUSTON — Doctors in the Texas Medical Center are shedding more light on the type of bone cancer Houston Mayor Sylvester Turner was treated for over the summer. During the annual State of the City ...
Niclosamide is an old antiparasitic with documented anticancer activity in laboratory models, but its clinical use for cancer has been limited by poor solubility and bioavailability. The authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results